Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Health Impact Study of Aquatabs in Tamale, Ghana

This study has been completed.
Sponsor:
Collaborators:
Medentech Ltd.
Emory University Center for Global Safe Water
NewEnergy
University for Development Studies, Tamale, Ghana
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00252928
First received: November 10, 2005
Last updated: October 29, 2007
Last verified: October 2007
  Purpose

The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.


Condition Intervention
Diarrhea
Other: Sodium dichloroisocyanurate (NaDCC) tablets
Other: Placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Prevention
Official Title: Health Impact Study of a Water Treatment Tablet, Aquatabs, in Tamale, Ghana

Resource links provided by NLM:


Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • Measure the impact of Aquatabs on diarrhea among persons in households in Tamale, Ghana. [ Time Frame: 12 weeks ]

Secondary Outcome Measures:
  • Assess the microbiological quality of household water among persons living in Tamale, Ghana. [ Time Frame: 12 weeks ]
  • Determine the acceptability of Aquatabs. [ Time Frame: 12 weeks ]

Enrollment: 240
Study Start Date: July 2006
Study Completion Date: November 2006
Arms Assigned Interventions
Placebo Comparator: A
Placebo group does not receive Aquatabs.
Other: Placebo
Placebo
Experimental: B
Intervention arms receives Aquatabs.
Other: Sodium dichloroisocyanurate (NaDCC) tablets
Intervention arm receives NaDCC tablets to use for to disinfect their household water for use for 20L of water. Ideally, disinfection occurs every day.
Other Name: Aquatabs

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Households with at least one child under 5 years old

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00252928

Locations
United States, Georgia
Emory University Center for Global Safe Water
Atlanta, Georgia, United States, 30322
Ghana
NewEnergy
Tamale, Ghana
University of Development Studies
Tamale, Ghana
Sponsors and Collaborators
Medentech Ltd.
Emory University Center for Global Safe Water
NewEnergy
University for Development Studies, Tamale, Ghana
Investigators
Principal Investigator: Seema Jain, MD Centers for Disease Control and Prevention
Principal Investigator: Robert Quick, MD Centers for Disease Control and Prevention
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00252928     History of Changes
Other Study ID Numbers: CDC-NCID-4730
Study First Received: November 10, 2005
Last Updated: October 29, 2007
Health Authority: United States: Federal Government
Ghana: University for Development Studies

Keywords provided by Centers for Disease Control and Prevention:
sodium dichloroisocyanurate
water purification
disinfection
Ghana

Additional relevant MeSH terms:
Troclosene
Anti-Infective Agents
Antifungal Agents
Antiviral Agents
Disinfectants
Pharmacologic Actions
Therapeutic Uses

ClinicalTrials.gov processed this record on November 23, 2014